Project Number CIHR-ROSA-NETO-2012 Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Year 2012 View Full Project Details for In vivo quantification of glutamatergic abnormalities in patients with Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 8. Novel Analyses, Methodologies and Techniques for Biomarker Discovery and Validation Researcher and Organization Principal Investigator ROSA-NETO, Pedro Principal Investigator First Name Pedro Principal Investigator Last Name ROSA-NETO Awardee Organization Douglas Hospital Research Centre (Verdun, Québec) Contact PI Country Canada Project Detail FY Overall Cost $244,398 Funding Organization Agency/Funding Organization Canadian Institutes of Health Research (CIHR) Funding Organization Country Canada
